Proactiveinvestors USA & Canada Bristol-Myers Squibb Co https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Bristol-Myers Squibb Co RSS feed en Tue, 29 Sep 2020 10:56:27 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Baird analysts stay Neutral on biotech sector as 2019 gets underway https://www.proactiveinvestors.com/companies/news/211977/baird-analysts-stay-neutral-on-biotech-sector-as-2019-gets-underway-211977.html Fri, 04 Jan 2019 14:24:00 -0500 https://www.proactiveinvestors.com/companies/news/211977/baird-analysts-stay-neutral-on-biotech-sector-as-2019-gets-underway-211977.html Bristol-Myers Squibb shares fall after FDA delays approval for lung cancer therapy https://www.proactiveinvestors.com/companies/news/207592/bristol-myers-squibb-shares-fall-after-fda-delays-approval-for-lung-cancer-therapy-207592.html Mon, 22 Oct 2018 16:23:00 -0400 https://www.proactiveinvestors.com/companies/news/207592/bristol-myers-squibb-shares-fall-after-fda-delays-approval-for-lung-cancer-therapy-207592.html Bristol-Myers Squibb's 2Q earnings beat Street on healthy sales of its blockbuster cancer drug Opdivo https://www.proactiveinvestors.com/companies/news/201677/bristol-myers-squibb-s-2q-earnings-beat-street-on-healthy-sales-of-its-blockbuster-cancer-drug-opdivo-201677.html Thu, 26 Jul 2018 16:05:00 -0400 https://www.proactiveinvestors.com/companies/news/201677/bristol-myers-squibb-s-2q-earnings-beat-street-on-healthy-sales-of-its-blockbuster-cancer-drug-opdivo-201677.html Cancer doctors offer key takeaways from American Society of Clinical Oncology conference https://www.proactiveinvestors.com/companies/news/198734/cancer-doctors-offer-key-takeaways-from-american-society-of-clinical-oncology-conference-198734.html Tue, 12 Jun 2018 20:44:00 -0400 https://www.proactiveinvestors.com/companies/news/198734/cancer-doctors-offer-key-takeaways-from-american-society-of-clinical-oncology-conference-198734.html Bristol Myers Squibb showcases positive results of new Phase 3 study evaluating cancer drug Opdivo https://www.proactiveinvestors.com/companies/news/198190/bristol-myers-squibb-showcases-positive-results-of-new-phase-3-study-evaluating-cancer-drug-opdivo-198190.html Mon, 04 Jun 2018 12:40:00 -0400 https://www.proactiveinvestors.com/companies/news/198190/bristol-myers-squibb-showcases-positive-results-of-new-phase-3-study-evaluating-cancer-drug-opdivo-198190.html Bristol-Myers beats 1Q estimates, guides higher for full-year 2018 on drug approvals https://www.proactiveinvestors.com/companies/news/195861/bristol-myers-beats-1q-estimates-guides-higher-for-full-year-2018-on-drug-approvals-195861.html Thu, 26 Apr 2018 12:40:00 -0400 https://www.proactiveinvestors.com/companies/news/195861/bristol-myers-beats-1q-estimates-guides-higher-for-full-year-2018-on-drug-approvals-195861.html Bristol-Myers falls after Citi analyst says Pfizer not interested in buying the drugmaker https://www.proactiveinvestors.com/companies/news/194888/bristol-myers-falls-after-citi-analyst-says-pfizer-not-interested-in-buying-the-drugmaker-194888.html Thu, 12 Apr 2018 18:00:00 -0400 https://www.proactiveinvestors.com/companies/news/194888/bristol-myers-falls-after-citi-analyst-says-pfizer-not-interested-in-buying-the-drugmaker-194888.html Bristol-Myers Squibb’s new dosing for cancer drug Opdivo gets FDA green light https://www.proactiveinvestors.com/companies/news/192680/bristol-myers-squibbs-new-dosing-for-cancer-drug-opdivo-gets-fda-green-light-192680.html Tue, 06 Mar 2018 12:49:00 -0500 https://www.proactiveinvestors.com/companies/news/192680/bristol-myers-squibbs-new-dosing-for-cancer-drug-opdivo-gets-fda-green-light-192680.html Bristol-Myers shares on the uptick after positive lung cancer trial results and market beating fourth quarter results https://www.proactiveinvestors.com/companies/news/191155/bristol-myers-shares-on-the-uptick-after-positive-lung-cancer-trial-results-and-market-beating-fourth-quarter-results-191155.html Mon, 05 Feb 2018 13:04:00 -0500 https://www.proactiveinvestors.com/companies/news/191155/bristol-myers-shares-on-the-uptick-after-positive-lung-cancer-trial-results-and-market-beating-fourth-quarter-results-191155.html Bristol-Myers Squibb drops on surprise third quarter profits miss https://www.proactiveinvestors.com/companies/news/186278/bristol-myers-squibb-drops-on-surprise-third-quarter-profits-miss-186278.html Thu, 26 Oct 2017 12:37:00 -0400 https://www.proactiveinvestors.com/companies/news/186278/bristol-myers-squibb-drops-on-surprise-third-quarter-profits-miss-186278.html Bristol Myers Squibb kidney cancer treatment meets endpoint of late-stage trial https://www.proactiveinvestors.com/companies/news/183617/bristol-myers-squibb-kidney-cancer-treatment-meets-endpoint-of-late-stage-trial-183617.html Thu, 07 Sep 2017 13:31:00 -0400 https://www.proactiveinvestors.com/companies/news/183617/bristol-myers-squibb-kidney-cancer-treatment-meets-endpoint-of-late-stage-trial-183617.html Bristol Myers Squibb buoyed by surge in sales of key drugs https://www.proactiveinvestors.com/companies/news/177002/bristol-myers-squibb-buoyed-by-surge-in-sales-of-key-drugs-177002.html Thu, 27 Apr 2017 13:07:00 -0400 https://www.proactiveinvestors.com/companies/news/177002/bristol-myers-squibb-buoyed-by-surge-in-sales-of-key-drugs-177002.html Bristol-Myers enters into two license deals with Biogen and Roche worth up to US$1.1bn https://www.proactiveinvestors.com/companies/news/176452/bristol-myers-enters-into-two-license-deals-with-biogen-and-roche-worth-up-to-us11bn-176452.html Thu, 13 Apr 2017 12:48:00 -0400 https://www.proactiveinvestors.com/companies/news/176452/bristol-myers-enters-into-two-license-deals-with-biogen-and-roche-worth-up-to-us11bn-176452.html Bristol-Myers shares hit by new lung cancer disappointment https://www.proactiveinvestors.com/companies/news/171953/bristol-myers-shares-hit-by-new-lung-cancer-disappointment-171953.html Fri, 20 Jan 2017 13:57:00 -0500 https://www.proactiveinvestors.com/companies/news/171953/bristol-myers-shares-hit-by-new-lung-cancer-disappointment-171953.html Bristol-Myers announces results for Opdivo https://www.proactiveinvestors.com/companies/news/170069/bristol-myers-announces-results-for-opdivo-170069.html Tue, 06 Dec 2016 21:26:00 -0500 https://www.proactiveinvestors.com/companies/news/170069/bristol-myers-announces-results-for-opdivo-170069.html Bristol Myers slumps as immunotherapy drug fails lung cancer trial https://www.proactiveinvestors.com/companies/news/129072/bristol-myers-slumps-as-immunotherapy-drug-fails-lung-cancer-trial-129072.html Fri, 05 Aug 2016 14:02:00 -0400 https://www.proactiveinvestors.com/companies/news/129072/bristol-myers-slumps-as-immunotherapy-drug-fails-lung-cancer-trial-129072.html Bristol Myers/ Janssen target lung cancer with I-O combo https://www.proactiveinvestors.com/companies/news/128646/bristol-myers-janssen-target-lung-cancer-with-i-o-combo-128646.html Tue, 26 Jul 2016 12:55:00 -0400 https://www.proactiveinvestors.com/companies/news/128646/bristol-myers-janssen-target-lung-cancer-with-i-o-combo-128646.html Bristol-Myers Squibb to get keys to Padlock https://www.proactiveinvestors.com/companies/news/124054/bristol-myers-squibb-to-get-keys-to-padlock-124054.html Wed, 23 Mar 2016 20:38:00 -0400 https://www.proactiveinvestors.com/companies/news/124054/bristol-myers-squibb-to-get-keys-to-padlock-124054.html Global drug industry profits set to slow, says Moody's https://www.proactiveinvestors.com/companies/news/123268/global-drug-industry-profits-set-to-slow-says-moody-s-123268.html Thu, 03 Mar 2016 15:00:00 -0500 https://www.proactiveinvestors.com/companies/news/123268/global-drug-industry-profits-set-to-slow-says-moody-s-123268.html Dual Therapeutics reports Bristol-Myers Squibb tie-up https://www.proactiveinvestors.com/companies/news/121125/dual-therapeutics-reports-bristol-myers-squibb-tie-up-121125.html Fri, 08 Jan 2016 13:29:00 -0500 https://www.proactiveinvestors.com/companies/news/121125/dual-therapeutics-reports-bristol-myers-squibb-tie-up-121125.html Bristol-Myers to take over Crioxyl Pharma in $2.1bn deal https://www.proactiveinvestors.com/companies/news/116957/bristol-myers-to-take-over-crioxyl-pharma-in-21bn-deal-116957.html Mon, 02 Nov 2015 13:26:00 -0500 https://www.proactiveinvestors.com/companies/news/116957/bristol-myers-to-take-over-crioxyl-pharma-in-21bn-deal-116957.html Bristol-Myers Squibb upgrades earnings guidance https://www.proactiveinvestors.com/companies/news/116728/bristol-myers-squibb-upgrades-earnings-guidance-116728.html Tue, 27 Oct 2015 16:37:00 -0400 https://www.proactiveinvestors.com/companies/news/116728/bristol-myers-squibb-upgrades-earnings-guidance-116728.html Bristol-Myers obtains rights to acquire drug developer Promedior for up to $1.25bn https://www.proactiveinvestors.com/companies/news/114569/bristol-myers-obtains-rights-to-acquire-drug-developer-promedior-for-up-to-125bn-114569.html Mon, 31 Aug 2015 16:43:00 -0400 https://www.proactiveinvestors.com/companies/news/114569/bristol-myers-obtains-rights-to-acquire-drug-developer-promedior-for-up-to-125bn-114569.html Bristol-Myers rises in premarket on JPMorgan upgrade https://www.proactiveinvestors.com/companies/news/97370/bristol-myers-rises-in-premarket-on-jpmorgan-upgrade-48065.html Mon, 16 Sep 2013 10:44:00 -0400 https://www.proactiveinvestors.com/companies/news/97370/bristol-myers-rises-in-premarket-on-jpmorgan-upgrade-48065.html Bristol-Myers Squibb Q4 results top views, shares rise https://www.proactiveinvestors.com/companies/news/92604/bristol-myers-squibb-q4-results-top-views-shares-rise-39781.html Thu, 24 Jan 2013 14:12:00 -0500 https://www.proactiveinvestors.com/companies/news/92604/bristol-myers-squibb-q4-results-top-views-shares-rise-39781.html Bristol-Myers Squibb posts Q3 loss on discontinued drug https://www.proactiveinvestors.com/companies/news/90670/bristol-myers-squibb-posts-q3-loss-on-discontinued-drug-36423.html Wed, 24 Oct 2012 14:11:00 -0400 https://www.proactiveinvestors.com/companies/news/90670/bristol-myers-squibb-posts-q3-loss-on-discontinued-drug-36423.html Bristol-Myers Squibb discontinues hepatitis C drug trial after patient death https://www.proactiveinvestors.com/companies/news/89006/bristol-myers-squibb-discontinues-hepatitis-c-drug-trial-after-patient-death-33803.html Fri, 24 Aug 2012 14:28:00 -0400 https://www.proactiveinvestors.com/companies/news/89006/bristol-myers-squibb-discontinues-hepatitis-c-drug-trial-after-patient-death-33803.html Bristol-Myers Squibb profit sheds 27% as patents expire https://www.proactiveinvestors.com/companies/news/88214/bristol-myers-squibb-profit-sheds-27-as-patents-expire-32461.html Wed, 25 Jul 2012 19:16:00 -0400 https://www.proactiveinvestors.com/companies/news/88214/bristol-myers-squibb-profit-sheds-27-as-patents-expire-32461.html Bristol-Myers rallies as it boosts stock buyback by $3 bln https://www.proactiveinvestors.com/companies/news/87394/bristol-myers-rallies-as-it-boosts-stock-buyback-by-3-bln-31103.html Wed, 27 Jun 2012 13:59:00 -0400 https://www.proactiveinvestors.com/companies/news/87394/bristol-myers-rallies-as-it-boosts-stock-buyback-by-3-bln-31103.html Bristol-Myers posts Q4 rise in profit, but falls short of Street views https://www.proactiveinvestors.com/companies/news/83164/bristol-myers-posts-q4-rise-in-profit-but-falls-short-of-street-views-24068.html Thu, 26 Jan 2012 15:45:00 -0500 https://www.proactiveinvestors.com/companies/news/83164/bristol-myers-posts-q4-rise-in-profit-but-falls-short-of-street-views-24068.html Bristol-Myers, AstraZeneca say FDA needs more data for diabetes drug https://www.proactiveinvestors.com/companies/news/82956/bristol-myers-astrazeneca-say-fda-needs-more-data-for-diabetes-drug--23743.html Thu, 19 Jan 2012 17:24:00 -0500 https://www.proactiveinvestors.com/companies/news/82956/bristol-myers-astrazeneca-say-fda-needs-more-data-for-diabetes-drug--23743.html Bristol-Myers Squibb to acquire Inhibitex for $2.5 bln https://www.proactiveinvestors.com/companies/news/82623/bristol-myers-squibb-to-acquire-inhibitex-for-25-bln-23186.html Mon, 09 Jan 2012 13:00:00 -0500 https://www.proactiveinvestors.com/companies/news/82623/bristol-myers-squibb-to-acquire-inhibitex-for-25-bln-23186.html Bristol-Myers' liver cancer drug fails to meet main goal of phase 3 study https://www.proactiveinvestors.com/companies/news/82431/bristol-myers-liver-cancer-drug-fails-to-meet-main-goal-of-phase-3-study-22854.html Fri, 23 Dec 2011 13:52:00 -0500 https://www.proactiveinvestors.com/companies/news/82431/bristol-myers-liver-cancer-drug-fails-to-meet-main-goal-of-phase-3-study-22854.html Bristol-Myers, Gladstone ink three year research collaboration deal https://www.proactiveinvestors.com/companies/news/82423/bristol-myers-gladstone-ink-three-year-research-collaboration-deal-22845.html Thu, 22 Dec 2011 19:30:00 -0500 https://www.proactiveinvestors.com/companies/news/82423/bristol-myers-gladstone-ink-three-year-research-collaboration-deal-22845.html Bristol-Myers Squibb inks deal to develop anti-Hep C drug combo https://www.proactiveinvestors.com/companies/news/81899/bristol-myers-squibb-inks-deal-to-develop-anti-hep-c-drug-combo-21950.html Fri, 02 Dec 2011 14:28:00 -0500 https://www.proactiveinvestors.com/companies/news/81899/bristol-myers-squibb-inks-deal-to-develop-anti-hep-c-drug-combo-21950.html Bristol-Myers, Pfizer announce phase 3 trial for Eliquis fails to meet main goals https://www.proactiveinvestors.com/companies/news/81425/bristol-myers-pfizer-announce-phase-3-trial-for-eliquis-fails-to-meet-main-goals-21052.html Mon, 14 Nov 2011 20:00:00 -0500 https://www.proactiveinvestors.com/companies/news/81425/bristol-myers-pfizer-announce-phase-3-trial-for-eliquis-fails-to-meet-main-goals-21052.html Bristol-Myers inks alliance with Aslan to build-on cancer drug https://www.proactiveinvestors.com/companies/news/81140/bristol-myers-inks-alliance-with-aslan-to-build-on-cancer-drug-20562.html Thu, 03 Nov 2011 19:05:00 -0400 https://www.proactiveinvestors.com/companies/news/81140/bristol-myers-inks-alliance-with-aslan-to-build-on-cancer-drug-20562.html Drug maker Bristol-Myers Squibb inks protein rights deal with Ambrx https://www.proactiveinvestors.com/companies/news/80016/drug-maker-bristol-myers-squibb-inks-protein-rights-deal-with-ambrx-18731.html Thu, 22 Sep 2011 17:34:00 -0400 https://www.proactiveinvestors.com/companies/news/80016/drug-maker-bristol-myers-squibb-inks-protein-rights-deal-with-ambrx-18731.html Bristol-Myers Squibb and AstraZeneca achieve main goal in type 2 diabetes drug trial https://www.proactiveinvestors.com/companies/news/79878/bristol-myers-squibb-and-astrazeneca-achieve-main-goal-in-type-2-diabetes-drug-trial-18469.html Fri, 16 Sep 2011 15:58:00 -0400 https://www.proactiveinvestors.com/companies/news/79878/bristol-myers-squibb-and-astrazeneca-achieve-main-goal-in-type-2-diabetes-drug-trial-18469.html Bristol-Myers inks deal to allow access of generic HIV drug to Africa and India https://www.proactiveinvestors.com/companies/news/78347/bristol-myers-inks-deal-to-allow-access-of-generic-hiv-drug-to-africa-and-india-15844.html Tue, 28 Jun 2011 20:19:00 -0400 https://www.proactiveinvestors.com/companies/news/78347/bristol-myers-inks-deal-to-allow-access-of-generic-hiv-drug-to-africa-and-india-15844.html Bristol-Myers, AstraZeneca achieve main goal of type 2 diabetes drug study https://www.proactiveinvestors.com/companies/news/78304/bristol-myers-astrazeneca-achieve-main-goal-of-type-2-diabetes-drug-study-15784.html Mon, 27 Jun 2011 15:55:00 -0400 https://www.proactiveinvestors.com/companies/news/78304/bristol-myers-astrazeneca-achieve-main-goal-of-type-2-diabetes-drug-study-15784.html Bristol-Myers Squibb To Buy Rights To Potential HIV Treatment Drug For $286 Million https://www.proactiveinvestors.com/companies/news/70665/bristol-myers-squibb-to-buy-rights-to-potential-hiv-treatment-drug-for-286-million--10984.html Mon, 20 Dec 2010 20:14:00 -0500 https://www.proactiveinvestors.com/companies/news/70665/bristol-myers-squibb-to-buy-rights-to-potential-hiv-treatment-drug-for-286-million--10984.html Bristol-Myers signs over anti-cancer compound rights in China to Simcere Pharmaceutical https://www.proactiveinvestors.com/companies/news/74651/bristol-myers-signs-over-anti-cancer-compound-rights-in-china-to-simcere-pharmaceutical--9762.html Wed, 03 Nov 2010 19:00:00 -0400 https://www.proactiveinvestors.com/companies/news/74651/bristol-myers-signs-over-anti-cancer-compound-rights-in-china-to-simcere-pharmaceutical--9762.html